Screener
Kymera Therapeutics KYMR Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Kymera Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
FAQ
- What is Kymera Therapeutics's operating margin?
- Kymera Therapeutics (KYMR) reported operating margin of -333.5% in Q2 2026.
- How has Kymera Therapeutics's operating margin changed year-over-year?
- Kymera Therapeutics's operating margin increased by 52.2% year-over-year, from -697.5% to -333.5%.
- What is the long-term trend for Kymera Therapeutics's operating margin?
- Over 5 years (2020 to 2025), Kymera Therapeutics's operating margin has grown at a 45.6% compound annual growth rate (CAGR), from -136.1% to -891.1%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Kymera Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude